Asarina Pharma (Sweden) Buy Hold or Sell Recommendation
| ASAP Stock | SEK 0.90 0.01 1.12% |
Assuming the 90 days trading horizon and your above-average risk tolerance, our recommendation regarding Asarina Pharma AB is 'Strong Sell'. Macroaxis provides Asarina Pharma buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ASAP positions. The advice algorithm takes into account all of Asarina Pharma's available fundamental, technical, and predictive indicators you will find on this site. Key drivers impacting Asarina Pharma's buy or sell advice are summarized below:
Real Value 0.82 | Hype Value 0.9 | Market Value 0.9 |
A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Asarina Pharma AB given historical horizon and risk tolerance towards Asarina Pharma. When Macroaxis issues a 'buy' or 'sell' recommendation for Asarina Pharma AB, the advice is generated through an automated system that utilizes algorithms and statistical models.
Asarina |
Execute Asarina Pharma Buy or Sell Advice
The Asarina recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Asarina Pharma AB. Macroaxis does not own or have any residual interests in Asarina Pharma AB or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Asarina Pharma's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Very Weak | Details | |
Volatility | Abnormally volatile | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Asarina Pharma Trading Alerts and Improvement Suggestions
| Asarina Pharma AB generated a negative expected return over the last 90 days | |
| Asarina Pharma AB has some characteristics of a very speculative penny stock | |
| Asarina Pharma AB has high historical volatility and very poor performance | |
| Asarina Pharma AB has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (31.66 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Asarina Pharma AB has accumulated about 21.71 M in cash with (42.5 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.04, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 39.0% of the company shares are held by company insiders |
Asarina Pharma Returns Distribution Density
The distribution of Asarina Pharma's historical returns is an attempt to chart the uncertainty of Asarina Pharma's future price movements. The chart of the probability distribution of Asarina Pharma daily returns describes the distribution of returns around its average expected value. We use Asarina Pharma AB price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Asarina Pharma returns is essential to provide solid investment advice for Asarina Pharma.
| Mean Return | -0.15 | Value At Risk | -7 | Potential Upside | 8.14 | Standard Deviation | 4.83 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Asarina Pharma historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Asarina Pharma Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Asarina Pharma or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Asarina Pharma's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Asarina stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over NYSE Composite | -0.06 | |
β | Beta against NYSE Composite | -1.3 | |
σ | Overall volatility | 4.96 | |
Ir | Information ratio | -0.05 |
Asarina Pharma Volatility Alert
Asarina Pharma AB exhibits very low volatility with skewness of 0.43 and kurtosis of 3.96. Asarina Pharma AB is a potential penny stock. Although Asarina Pharma may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Asarina Pharma AB. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on Asarina instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Asarina Pharma Fundamentals Vs Peers
Comparing Asarina Pharma's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Asarina Pharma's direct or indirect competition across all of the common fundamentals between Asarina Pharma and the related equities. This way, we can detect undervalued stocks with similar characteristics as Asarina Pharma or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Asarina Pharma's fundamental indicators could also be used in its relative valuation, which is a method of valuing Asarina Pharma by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Asarina Pharma to competition |
| Fundamentals | Asarina Pharma | Peer Average |
| Return On Equity | -0.7 | -0.31 |
| Return On Asset | -0.46 | -0.14 |
| Current Valuation | 10.34 M | 16.62 B |
| Shares Outstanding | 22.64 M | 571.82 M |
| Shares Owned By Insiders | 38.91 % | 10.09 % |
| Shares Owned By Institutions | 31.91 % | 39.21 % |
| Price To Book | 1.17 X | 9.51 X |
| EBITDA | (37.52 M) | 3.9 B |
| Net Income | (31.66 M) | 570.98 M |
| Cash And Equivalents | 21.71 M | 2.7 B |
| Cash Per Share | 8.04 X | 5.01 X |
| Total Debt | 5.3 M | 5.32 B |
| Current Ratio | 18.10 X | 2.16 X |
| Book Value Per Share | 0.85 X | 1.93 K |
| Cash Flow From Operations | (42.5 M) | 971.22 M |
| Earnings Per Share | (1.57) X | 3.12 X |
| Number Of Employees | 2 | 18.84 K |
| Beta | 0.43 | -0.15 |
| Market Capitalization | 29.61 M | 19.03 B |
| Total Asset | 30.36 M | 29.47 B |
| Z Score | -0.3 | 8.72 |
| Net Asset | 30.36 M |
Asarina Pharma Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Asarina . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Asarina Pharma Buy or Sell Advice
When is the right time to buy or sell Asarina Pharma AB? Buying financial instruments such as Asarina Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Asarina Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Giant Impact Thematic Idea Now
Giant Impact
An experimental equal-weighted decomposition of large high potential stocks based on Macroaxis scoring framework. The Giant Impact theme has 44 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Giant Impact Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Asarina Pharma Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Complementary Tools for Asarina Stock analysis
When running Asarina Pharma's price analysis, check to measure Asarina Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Asarina Pharma is operating at the current time. Most of Asarina Pharma's value examination focuses on studying past and present price action to predict the probability of Asarina Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Asarina Pharma's price. Additionally, you may evaluate how the addition of Asarina Pharma to your portfolios can decrease your overall portfolio volatility.
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |